Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,388,816
+$1,572,360 QoQ
Shares Held
127,676
+55.6% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. RLAY ranks #74 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,388,816 | 127,676 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $816,456 | 82,056 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $923,898 | 109,208 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $586,288 | 112,316 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $388,612 | 112,316 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $338,542 | 129,215 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $514,529 | 124,886 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $872,941 | 123,297 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $572,493 | 87,806 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $722,821 | 87,087 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $834,546 | 75,799 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $637,468 | 75,799 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $962,698 | 76,648 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,236,237 | 75,060 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $931,269 | 62,334 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,414,164 | 63,217 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,014,664 | 60,577 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $1,527,926 | 51,050 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,555,891 | 50,664 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,246,790 | 39,543 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,215,555 | 33,221 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $892,873 | 25,828 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $568,166 | 13,671 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,581,451 | 37,132 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||